CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

CUSIP: 23284F105

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 7 signals
Share change
-7,947,264
Put/Call ratio
0%
SEC-reported price per share
$1.83
Number of holders
86
Value change
-$17,825,825
Number of buys
43
Open additional details 1 more signal available
Number of sells
64
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
216,973,139

Security key

23284F105

Report period

Q2 2022

Institutions

86

Top holders

10

Ownership snapshot

Top reported holders of CTMX - CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
0/15
Latest evidence
31 Mar 2022
13F Highest disclosed value: $15,496,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BVF INC/IL has the largest disclosed position value at $15.5M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BVF INC/IL's linked filing trail.
Disclosed position value Top 5
BVF INC/IL $15.5M
RTW INVESTMENTS, LP $15.43M
VANGUARD GROUP INC $13.94M
BlackRock Finance, Inc. $13.33M
Point72 Asset Management, L.P. $11.67M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BVF INC/IL
13F
Company
13F
—
denominator unverified
$15,496,000
5,803,700 shares
— 31 Mar 2022
RTW INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$15,432,000
5,779,700 shares
— 31 Mar 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$13,945,000
5,222,886 shares
— 31 Mar 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$13,328,000
4,992,094 shares
— 31 Mar 2022
Point72 Asset Management, L.P.
13F
Company
13F
—
denominator unverified
$11,671,000
4,371,300 shares
— 31 Mar 2022
Rubric Capital Management LP
13F
Company
13F
—
denominator unverified
$6,425,000
2,406,449 shares
— 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
86
Shares
45,579,430
Rows available
86
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
112
Q2 2022 holders
86
Holder diff
-26
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .